NATR

In the past six months, Nature's Sunshine Products, Inc. stock has experienced a 48.01% increase. Key events impacting the stock include strong Q1 2026 financial results, with net sales rising 9% and GAAP diluted EPS increasing 16%. Management reaffirmed its full-year 2026 outlook for net sales of $500–$515 million and adjusted EBITDA of $50–$54 million. The company repurchased 20,000 shares for $0.5 million and shareholders approved a new 2026 Stock Incentive Plan. John Hnanicek was appointed as Chief Technology Officer. There was an announcement regarding a secondary public offering of common stock by Fosun Pharma USA, Inc. Nature's Sunshine CEO Terrence Moorehead was to step down.